Hamps Bio Limited
Incorporated in 2007, Hamps Bio Ltd is in the business of Pharmaceutical Formulation and Freeze-Drying Ingredient Manufacturing and Distribution[1]
- Market Cap ₹ 21.8 Cr.
- Current Price ₹ 25.0
- High / Low ₹ 26.6 / 13.4
- Stock P/E
- Book Value ₹ 9.30
- Dividend Yield 0.00 %
- ROCE -3.36 %
- ROE -8.76 %
- Face Value ₹ 10.0
Pros
- Company's working capital requirements have reduced from 96.6 days to 65.2 days
Cons
- Stock is trading at 2.69 times its book value
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 6.67 | 8.46 | |
| 5.90 | 8.42 | |
| Operating Profit | 0.77 | 0.04 |
| OPM % | 11.54% | 0.47% |
| 0.15 | 0.33 | |
| Interest | 0.14 | 0.25 |
| Depreciation | 0.38 | 0.82 |
| Profit before tax | 0.40 | -0.70 |
| Tax % | 25.00% | 4.29% |
| 0.30 | -0.74 | |
| EPS in Rs | 0.34 | -0.85 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -347% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | -9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 4.36 | 8.71 |
| Reserves | 4.44 | -0.61 |
| 2.97 | 6.89 | |
| 1.02 | 0.93 | |
| Total Liabilities | 12.79 | 15.92 |
| 2.48 | 9.10 | |
| CWIP | 3.38 | 1.08 |
| Investments | 0.00 | 0.07 |
| 6.93 | 5.67 | |
| Total Assets | 12.79 | 15.92 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| -1.76 | -0.71 | |
| -6.21 | -2.93 | |
| 8.00 | 3.72 | |
| Net Cash Flow | 0.04 | 0.07 |
| Free Cash Flow | -5.48 | -5.84 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -214% | -1,775% |
Ratios
Consolidated / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 65.12 | 68.60 |
| Inventory Days | 434.35 | 298.01 |
| Days Payable | 109.50 | 39.27 |
| Cash Conversion Cycle | 389.97 | 327.33 |
| Working Capital Days | 128.05 | 65.15 |
| ROCE % | -3.36% |
Insights
In beta| Oct 2024 | Mar 2026 | |
|---|---|---|
| Customer Count (Pharma and FDFP) customers |
|
|
| FMCG Division SKU Count (FZYZEY brand) SKUs (freeze-dried products) |
||
| Freeze-dried Production Volume (monthly average) tons per month |
||
| Installed Freeze-drying Capacity (Ankleshwar and Surat) tons per month |
||
| Pharma Division Product Count items (dosage forms) |
||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Certificate under Regulation 74 (5) of SEBI (DP) Regulation, 2018 for the quarter ended 30th September 2026.
-
Closure of Trading Window
- Trading window closed from 1 Oct 2026 until 48 hours after half-year results for 30 Sep 2026.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
-
Board Meeting Outcome for Board Meeting Outcome
- Board approved higher remuneration for CMD, WTD, CFO and director on September 9, 2026.
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- 19th AGM held on September 9, 2026; shareholders considered FY26 accounts, director reappointment, and office shift.
Business Overview:[1]
HBL is in the business of ethical marketing and distribution of pharmaceutical formulations across wide range of dosage including tablets, syrups, capsules, injectables, oil, gel and powder used as medicine & nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers.